-
-
C153471-100gProduct Describtion:Cetilistat (ATL-962), an inhibitor of pancreatic lipase, acts as an effective anti-obesity agent. Cetilistat inhibits rat and human pancreatic lipase activity with IC50s of 54.8 nM, and 5.95 nM, respectively.
-
C153471-1gProduct Describtion:Cetilistat (ATL-962), an inhibitor of pancreatic lipase, acts as an effective anti-obesity agent. Cetilistat inhibits rat and human pancreatic lipase activity with IC50s of 54.8 nM, and 5.95 nM, respectively.
-
C153471-25gProduct Describtion:Cetilistat (ATL-962), an inhibitor of pancreatic lipase, acts as an effective anti-obesity agent. Cetilistat inhibits rat and human pancreatic lipase activity with IC50s of 54.8 nM, and 5.95 nM, respectively.
-
C153471-5gProduct Describtion:Cetilistat (ATL-962), an inhibitor of pancreatic lipase, acts as an effective anti-obesity agent. Cetilistat inhibits rat and human pancreatic lipase activity with IC50s of 54.8 nM, and 5.95 nM, respectively.
-
-
-
C413779-100mgInformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B
-
C413779-10mgInformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B
-
C413779-1mgInformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B
-
C413779-25mgInformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B
-
C413779-50mgInformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B